GFR of stage 3 chronic kidney disease is
The user mentioned that the correct answer is option C, but the options are missing. Wait, the original question's options are A, B, C, D but the text is empty. That's a problem. How can I explain without knowing the options? Maybe the options were accidentally left out. The correct answer provided is "[C] 30-59 mL/min/1.73 mΒ²". So I need to work with that.
For the core concept, it's the GFR stages of CKD. The stages are from 1 to 5, each with decreasing GFR. Stage 1 is normal or increased GFR (β₯90), stage 2 is mild (60-89), stage 3 is moderate (30-59), stage 4 is severe (15-29), and stage 5 is kidney failure (<15 or on dialysis). Why is option C correct? Because stage 3 CKD is defined by a GFR between 30-59. This stage indicates moderate kidney damage, often from conditions like diabetes or hypertension. The GFR is reduced but not yet at the severe level. Now, the incorrect options. If the options were, say, A: 60-89 (stage 2), B: 15-29 (stage 4), D: <15 (stage 5), then those would be wrong. Each wrong option is from a different stage. Need to explain why those ranges don't fit stage 3. Clinical pearl: Remembering the stages by the GFR ranges is crucial. A mnemonic could be "Stage 3 is 30-59," and each subsequent stage decreases by 30. Also, stage 3 is a turning point where complications like anemia and bone disease start to become more common. Putting it all together in the required format. Make sure to mention the exact GFR range for stage 3, explain why the other ranges are for different stages, and highlight the importance of this stage in CKD progression.
**Core Concept**
Chronic kidney disease (CKD) is staged based on estimated glomerular filtration rate (eGFR). Stage 3 CKD corresponds to a moderate decline in kidney function, defined by an eGFR of **30β59 mL/min/1.73 mΒ²**. This stage is further divided into 3a (45β59) and 3b (30β44) for more precise management.
**Why the Correct Answer is Right**
Stage 3 CKD (eGFR 30β59 mL/min/1.73 mΒ²) indicates reduced kidney function but not yet severe enough to require renal replacement therapy. The kidneys retain 40β70% of normal function, often with structural damage (e.g., diabetic nephropathy, glomerulonephritis). At this stage, complications like anemia, metabolic acidosis, and phosphate retention become clinically significant, necess